Search Results 2481-2490 of 41215 for oral

  1. Publications - Michael Keeney, M.D. - Mayo Clinic

    Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 May; 121: (5)542-549.e1. View PubMed; Chang SY, Keeney M, Law M, Donovan J, Aubry MC, Garcia J. Detection of ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  3. Skin cancer - Doctors and departments - Mayo Clinic

    Kevin Arce, M.D., D.M.D.. Oral and Maxillofacial Surgeon. Rochester, MN. Areas of focus: Cancer treatment, Tracheostomy, Jaw surgery, Flap surgery, Cancer ...

  4. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    John M. Nathan, M.D.,D.D.S.. Surgeon; Sleep Medicine Specialist; Oral and Maxillofacial Surgeon. Rochester, MN ...

  5. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    John M. Nathan, M.D.,D.D.S.. Surgeon; Sleep Medicine Specialist; Oral and Maxillofacial Surgeon. Rochester, MN ...

  6. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    John M. Nathan, M.D.,D.D.S.. Surgeon; Sleep Medicine Specialist; Oral and Maxillofacial Surgeon. Rochester, MN ...

  7. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    John M. Nathan, M.D.,D.D.S.. Surgeon; Sleep Medicine Specialist; Oral and Maxillofacial Surgeon. Rochester, MN ...

  8. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgeon. Rochester, MN. Areas of focus: Cancer treatment, Tracheostomy, Jaw surgery, Flap surgery, Cancer rehabilitation, Skin biopsy ...

  9. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    John M. Nathan, M.D.,D.D.S.. Surgeon; Sleep Medicine Specialist; Oral and Maxillofacial Surgeon. Rochester, MN ...

  10. Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer - Mayo Clinic

    ... oral agents are not eligible; Patients with known hypersensitivity to any TZD oral agents are not eligible; Eastern Cooperative Oncology Group (ECOG) ...